Skip to main navigation Skip to search Skip to main content

Phase III multicenter trial comparing the efficacy of 2% dodecafluoropentane emulsion (EchoGen) and sonicated 5% human albumin (Albunex) as ultrasound contrast agents in patients with suboptimal echocardiograms

  • Paul A. Grayburn
  • , James L. Weiss
  • , Terrence C. Hack
  • , Elizabeth Klodas
  • , Joel S. Raichlen
  • , Manni A. Vannan
  • , Allan L. Klein
  • , Dalane W. Kitzman
  • , Steven G. Chrysant
  • , Jerald L. Cohen
  • , David Abrahamson
  • , Elyse Foster
  • , Julio E. Perez
  • , Gerard P. Aurigemma
  • , Julio A. Panza
  • , Michael H. Picard
  • , Benjamin F. Byrd
  • , Douglas S. Segar
  • , Stuart A. Jacobson
  • , David J. Sahn
    • Anthony N. Demaria

Research output: Contribution to journal › Article › peer-review

114   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Phase III multicenter trial comparing the efficacy of 2% dodecafluoropentane emulsion (EchoGen) and sonicated 5% human albumin (Albunex) as ultrasound contrast agents in patients with suboptimal echocardiograms'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry